期刊文献+

支气管哮喘患者吸入激素治疗依从性分析 被引量:16

STUDY ON COMPLIANCE OF GLUCOLORTICOID IN TREATMENT OF ASTHMA
在线阅读 下载PDF
导出
摘要 [目的]了解支气管哮喘患者吸入糖皮质激素的依从性及其影响因素。[方法]对23例哮喘患者进行门诊问卷调查。[结果]23例中仅有4例基本遵从医嘱。其余19例均有不同程度的不遵从医嘱现象。平均依从率17.39%。影响因素包括恐惧激素、用药方法不当及用药副作用、经济困难、过早停药或间断用药等。大多数患者均对哮喘相关知识缺乏认识。[结论]应对哮喘患者进行长期系统的教育和管理、丰富患者的哮喘知识及加强对患者对激素应用的认识,是提高哮喘患者对激素吸入依从性的关键。 [ Objective] To study on the comphance of glucolorticoid in treatment of asthma and the intluntial tactors. [Methods] A questionnaire survey was applied among patients who complained to our clinic for asthma. [Results] Among the 23 patients, only 4 received follow up studies, the other 19 case didn't join in treatment planning with doctors. The rate of compliance was 17.39%. The influntial factors included worry about ICS, inappropriate use of MDI, cost, inhaled use of steroid and so on. Most of the patients knew little about the mechanisms and medications of asthma. [Conclusion] Long term systematic education and management of asthmatic patients for proper use of medicine can greatly improve the compliance of glucolorticold treatment.
出处 《现代预防医学》 CAS 北大核心 2007年第15期2970-2971,共2页 Modern Preventive Medicine
关键词 支气管哮喘 肾上腺糖皮质激素吸入 依从性 Asthma Inhaled corticosteroids (ICS) Compliance
  • 相关文献

参考文献6

二级参考文献41

  • 1Corrigan CJ. Glucocorticoid unresponsiveness in severe ulcerative colitis. Gut,1999,45:324-325.
  • 2Alvares P. Gemou - Engesaeth V, Fagerhol MK, et al. Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therrapy. Pediatrics,2002,109:E 24.
  • 3Newman SP. Lung distrbution of inhaled drugs. Br J Clin Pharmacol,2001,52 :716 - 719.
  • 4Marks GB, Toelle BG, Belousova E, et al. Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax, 2002, 57:104- 109.
  • 5Sakai H. Comparison of three steatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, sterioid department asthma Ann. Allergy Asthma Immund, 1998,80:494 - 498.
  • 6Mattos W, Lim S, Russell R, et al. Matrix metalloproteinase - 9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled coricoetemids. Chest ,2002,122:1543 - 1552.
  • 7Gelfand EW, Landwehr LP, Ested B, et al. Intravenous immune globulin: an alternative therapy in steroid - dependent allergic diseases. Clin Exp Immunol,1996,104(Suppl) :61 - 66.
  • 8Israel E, Fischer AB. The pivotal role of 5 - lipoxygenase products in the reaction of aspirin - sensitive asthmatics to aspirln. Am Respir Dis, 1993,148(6 Pt 1):1447- 1451.
  • 9Spector SL,Smith LJ,Glass M.Effects of 6 weeks of therapy with oral doses of ICI204,219, a leukotriene I)4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Triallsts Group. Am J Raspir Crit Care Med,1994,150:618 - 623.
  • 10Newman SP. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs? Br J Clin Pharmacol,2000,49:529 - 537.

共引文献139

同被引文献143

引证文献16

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部